News for Healthier Living

Virtual Tumor Predict Response to Liver Cancer Immunotherapy

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular carcinoma (HCC) would most benefit from combination treatment using immunotherapy and a targeted therapy that blocks the growth signals that the tumor depends on. The work, supported in part by the National Institutes of Health, was published online July 14 in the Proceedings of the National Academy of Sciences.

July 15, 2026


July 15 2026

July 14 2026

July 13 2026

July 12 2026

July 10 2026

July 9 2026

July 8 2026

July 7 2026

July 6 2026

July 3 2026

July 2 2026

July 1 2026